Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Current Assets: 2016-2024

Historic Current Assets for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $285.9 million.

  • Organogenesis Holdings' Current Assets rose 25.68% to $299.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $299.7 million, marking a year-over-year increase of 25.68%. This contributed to the annual value of $285.9 million for FY2024, which is 27.06% up from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Current Assets is $285.9 million, which was up 27.06% from $225.0 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Current Assets registered a high of $285.9 million during FY2024, and its lowest value of $174.3 million during FY2020.
  • Its 3-year average for Current Assets is $244.5 million, with a median of $225.0 million in 2023.
  • In the last 5 years, Organogenesis Holdings' Current Assets surged by 38.81% in 2020 and then dropped by 1.93% in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Current Assets stood at $174.3 million in 2020, then surged by 30.19% to $227.0 million in 2021, then decreased by 1.93% to $222.6 million in 2022, then increased by 1.09% to $225.0 million in 2023, then increased by 27.06% to $285.9 million in 2024.